• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受霉酚酸酯治疗的小儿肾移植受者的播散性水痘感染

Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil.

作者信息

Rothwell W S, Gloor J M, Morgenstern B Z, Milliner D S

机构信息

Mayo Eugenio Litta Children's Hospital and the Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

Transplantation. 1999 Jul 15;68(1):158-61. doi: 10.1097/00007890-199907150-00030.

DOI:10.1097/00007890-199907150-00030
PMID:10428286
Abstract

BACKGROUND

Mycophenolate mofetil (MMF) is a new immune suppressive agent, effective in the prevention of acute rejection after renal transplantation.

METHODS

The study was a retrospective review of records of pediatric renal transplant recipients from 1985 to the present.

RESULTS

Since October 1995, the immune suppression protocol for pediatric renal transplant recipients at Mayo Eugenio Litta Children's Hospital has included MMF, prednisone, and cyclosporine A. During that time, 19 children and adolescents have received renal allografts, 17 of whom were seropositive for varicella antibody before transplantation, while 2 were seronegative. Varicella infection occurred in 3 of 19 patients (15.8%), all 3 of whom had serologically documented immunity to varicella virus before transplantation. All episodes occurred within 12 months of transplantation. All had generalized vesicular lesions without dermatomal distribution. None of the patients developed fever, respiratory, mucocutaneous, or central nervous system manifestations. All were managed with oral acyclovir, and had an uncomplicated recovery without neuralgia. By contrast, of 74 consecutive patients transplanted before use of MMF, only 1 patient (1.4%) had varicella infection after transplantation (P=0.026).

CONCLUSION

The enhanced immunosuppression achieved with MMF appears to be associated with increased susceptibility to varicella infection.

摘要

背景

霉酚酸酯(MMF)是一种新型免疫抑制剂,对预防肾移植术后急性排斥反应有效。

方法

本研究是对1985年至今小儿肾移植受者记录的回顾性分析。

结果

自1995年10月起,梅奥尤金尼奥·利塔儿童医院对小儿肾移植受者的免疫抑制方案包括MMF、泼尼松和环孢素A。在此期间,19名儿童和青少年接受了肾移植,其中17人移植前水痘抗体呈血清学阳性,2人呈血清学阴性。19例患者中有3例(15.8%)发生水痘感染,所有3例在移植前血清学检查均证明对水痘病毒有免疫力。所有感染均发生在移植后12个月内。所有患者均出现全身性水疱性皮疹,无皮节分布。所有患者均未出现发热、呼吸道、黏膜皮肤或中枢神经系统表现。所有患者均接受口服阿昔洛韦治疗,恢复顺利,无神经痛。相比之下,在使用MMF之前连续移植的74例患者中,只有1例(1.4%)在移植后发生水痘感染(P=0.026)。

结论

MMF所致的免疫抑制增强似乎与水痘感染易感性增加有关。

相似文献

1
Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil.接受霉酚酸酯治疗的小儿肾移植受者的播散性水痘感染
Transplantation. 1999 Jul 15;68(1):158-61. doi: 10.1097/00007890-199907150-00030.
2
Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil.成人肾移植受者的播散性水痘感染:霉酚酸酯的作用
Transplant Proc. 2003 Aug;35(5):1758-9. doi: 10.1016/s0041-1345(03)00684-5.
3
Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.儿童肾移植中未进行诱导治疗的霉酚酸酯:治疗12个月后的结果。德国儿童肾移植研究组
Transplantation. 2001 Mar 15;71(5):638-44. doi: 10.1097/00007890-200103150-00010.
4
Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.霉酚酸酯在小儿肾移植中的应用:不进行诱导治疗与使用巴利昔单抗进行诱导治疗的对比
Pediatr Transplant. 2005 Feb;9(1):80-3. doi: 10.1111/j.1399-3046.2005.00267.x.
5
The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.霉酚酸酯与硫唑嘌呤及霉酚酸的药代动力学对肾移植后急性排斥反应发生率和感染并发症的影响。
Transplant Proc. 2005 May;37(4):1751-3. doi: 10.1016/j.transproceed.2005.03.072.
6
Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.霉酚酸酯预防尸体肾移植受者急性排斥反应的研究。美国肾移植霉酚酸酯研究组。
Transplantation. 1995 Aug 15;60(3):225-32. doi: 10.1097/00007890-199508000-00003.
7
Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen?霉酚酸酯是否会增加初始接受两药方案治疗的稳定肾移植受者的感染发生率?
Transplant Proc. 2004 Sep;36(7):2122-3. doi: 10.1016/j.transproceed.2004.08.015.
8
Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients.霉酚酸酯、微乳环孢素和泼尼松作为小儿肝移植受者的初始免疫抑制治疗。
Liver Transpl Surg. 1999 Mar;5(2):136-43. doi: 10.1002/lt.500050208.
9
Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.接受环孢素A和霉酚酸酯治疗的小儿肾移植受者成功停用类固醇:四年后的结果
Transplantation. 2004 Jul 27;78(2):228-34. doi: 10.1097/01.tp.0000133536.83756.1f.
10
Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.达利珠单抗诱导治疗、他克莫司、霉酚酸酯和类固醇作为原发性肾移植受者的免疫抑制方案。
Transplantation. 2002 Apr 15;73(7):1100-6. doi: 10.1097/00007890-200204150-00015.

引用本文的文献

1
Fatal visceral disseminated varicella zoster virus infection during initial remission induction therapy in a patient with lupus nephritis: a case report and review of the literature.狼疮性肾炎患者初始缓解诱导治疗期间发生致命性内脏播散性水痘-带状疱疹病毒感染:1例病例报告并文献复习
CEN Case Rep. 2025 Jun;14(3):477-485. doi: 10.1007/s13730-024-00950-7. Epub 2024 Dec 12.
2
A survival case of visceral disseminated varicella zoster virus infection in a patient with systemic lupus erythematosus.系统性红斑狼疮患者内脏播散性水痘带状疱疹病毒感染的存活病例。
BMC Nephrol. 2023 Jun 8;24(1):164. doi: 10.1186/s12882-023-03223-0.
3
Herpes zoster duplex bilateralis symmetricus in an immunocompromised patient with recent varicella infection.
一名近期患水痘的免疫功能低下患者出现双侧对称性带状疱疹。
IDCases. 2021 Nov 18;26:e01349. doi: 10.1016/j.idcr.2021.e01349. eCollection 2021.
4
Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.119 例日本系统性红斑狼疮患者吗替麦考酚酯安全性的真实世界经验:一项回顾性单中心研究。
Biomed Res Int. 2021 Jan 23;2021:8630596. doi: 10.1155/2021/8630596. eCollection 2021.
5
Varicella-zoster virus post-exposure management and prophylaxis: A review.水痘-带状疱疹病毒暴露后管理与预防:综述
Prev Med Rep. 2019 Nov 6;16:101016. doi: 10.1016/j.pmedr.2019.101016. eCollection 2019 Dec.
6
Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report.狼疮性肾炎和类风湿关节炎患者在初始缓解诱导治疗期间发生致命性内脏播散性水痘带状疱疹感染——可能与霉酚酸酯和大剂量糖皮质激素治疗有关:一例病例报告
BMC Res Notes. 2018 Mar 5;11(1):165. doi: 10.1186/s13104-018-3271-3.
7
Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.利妥昔单抗联合霉酚酸酯治疗儿童狼疮性肾炎。
Pediatr Nephrol. 2018 Jan;33(1):111-116. doi: 10.1007/s00467-017-3767-4. Epub 2017 Aug 5.
8
Chickenpox infection after renal transplantation.肾移植后水痘感染。
Clin Kidney J. 2012 Jun;5(3):203-6. doi: 10.1093/ckj/sfs036. Epub 2012 Apr 25.
9
Mycophenolate mofetil in the treatment of systemic lupus erythematosus.霉酚酸酯治疗系统性红斑狼疮
Eurasian J Med. 2009 Dec;41(3):180-5.
10
VZV encephalitis following successful treatment of CMV infection in a patient with kidney transplant.一名肾移植患者在成功治疗巨细胞病毒感染后发生水痘带状疱疹病毒脑炎。
BMJ Case Rep. 2014 Dec 2;2014:bcr2014206655. doi: 10.1136/bcr-2014-206655.